Association and multimodal model of retinal and blood‐based biomarkers for detection of preclinical Alzheimer’s disease

Swetha Ravichandran, Peter J. Snyder, Jessica Alber, Andreas Jeromin, Lauren E Chaby, Edmund Arthur · 2025

Read Association and multimodal model of retinal and blood‐based biomarkers for detection of preclinical Alzheimer’s disease by Swetha Ravichandran, Peter J. Snyder, Jessica Alber, Andreas Jeromin, Lauren E Chaby, Edmund Arthur (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11716755.txt.

Description

Swetha Ravichandran and co-authors test whether eye and blood markers together can flag preclinical Alzheimer's disease, in a 2025 paper. Blood ratios and proteins tied to amyloid and nerve damage are promising early signals. The retina, as a window on the brain, may add its own clues before symptoms appear.

The study drew 81 cognitively healthy adults, averaging sixty-seven years old, from a retinal imaging study of Alzheimer's disease. Blood tests measured amyloid ratio and three marker proteins, while eye scans captured retinal surface changes and nerve fiber thickness. A subgroup of fifty-seven eyes fed a combined model separating preclinical disease from controls. Linking the two marker families could sharpen silent-stage detection.

Catalog record

CREATORSwetha Ravichandran, Peter J. Snyder, Jessica Alber, Andreas Jeromin, Lauren E Chaby, Edmund Arthur
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11716755

Browse the full library · About the Tower of Babel